A drug that uses an antibody to target cancer cells shrank tumours in women with triple negative breast cancer that has spread, according to a clinical trial.
As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.
Combining new ways to measure molecules could lead to the most accurate picture of tumours ever created. We explore the science behind the approach.
Our new report looks at what GPs know about offering tamoxifen and aspirin to lower the risk of, or prevent, certain cancers.
We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge
A new Cancer Research UK report reveals that GPs want more support when offering drugs that lower the risk of certain cancers.
Scientists have created a ‘map’ linking cell shape and genes in breast cancer, and matched it to real disease outcomes.
Meet our new leaders, who are spearheading research to tackle some of the biggest questions we need to answer to help more people survive cancer.
Around a third of women diagnosed with invasive breast cancer or DCIS through screening in Denmark are likely to receive unnecessary treatment.